{"disease":{"id":"measles-mumps-rubella-vaccine","name":"measles mumps rubella vaccine"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT01681992","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Combined Measles-mumps-rubella (MMR) Vaccine in Children in Their Second Year of Life","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4538,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT02184572","title":"Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Measles, Mumps and Rubella (MMR) Vaccine (209762) Compared to Merck & Co., Inc.'s MMR Vaccine in Healthy Children 12 to 15 Months of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1742,"lead_sponsor_name":"GlaxoSmithKline","has_results":true},{"nct_id":"NCT00861744","title":"Immunogenicity of GSKs' MMR Vaccine (209762) vs. M-M-R® II, When Given With Routine Vaccines at 12-15 Months of Age","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":1259,"lead_sponsor_name":"GlaxoSmithKline","has_results":true}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}